Pneumology

Maria Molina Molina / Jordi Dorca Sargatal
PRINCIPAL INVESTIGATORS
  • Eva Farrero Muñoz
  • Rosa Maria Lopez Lisbona
  • Jesus Ribas Sola
  • Ana Cordoba Izquierdo
  • Vanesa Vicens Zygmunt
  • Noelia Cubero Frutos
  • Mariana Mercedes Muñoz Esquerre
  • Maria Dela Salud Santos Perez
CLINICAL RESEARCHERS
  • Carmen Monasterio Ponsa
  • Roger Llatjos Sanuy
  • Marta Lopez Sanchez
  • Neus Salord Oleo
  • Susana Padrones Sanchez
  • Enric Prats Soro
  • Rosa Planas Balague
POSTDOCTORAL RESEARCHERS (R2)
  • Ana Montes Worboys
PREDOCTORAL RESEARCHERS (R1)
  • Merce Gasa Galmes
  • Samantha Aso Gonzalez
  • Lurdes Planas Cerezales
  • Carlos Esteban Machahua Huamani
  • Ester Cuevas Sales
SCIENTIFIC SUPPORT
  • Montserrat Navarro Rodriguez
  • Maria Jose Rodriguez Lopez
MANAGEMENT SUPPORT
  • Jessica Germaine Shull
Translational Medicine
Cardiovascular, Respiratory and Systemic Diseases and cellular aging

Scientific production

34

PAPERS

Impact factor: 179,169

7 PUBLICATIONS IN FIRST DECILE

16 PUBLICATIONS IN FIRST QUARTILE

Selected publications

  • Maher, Toby M.; Corte, Tamera J.; Fischer, Aryeh; Kreuter, Michael; Lederer, David J.; Molina-Molina, Maria; Axmann, Judit; Kirchgaessler, Klaus-Uwe; Samara, Katerina; Gilberg, Frank; Cottin, Vincent. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial. LANCET RESPIRATORY MEDICINE. 10.1016/S2213-2600(19)30341-8
  • Allen, Richard J.; Guillen-Guio, Beatriz; Oldham, Justin M.; Ma, Shwu-Fan; Dressen, Amy; Paynton, Megan L.; Kraven, Luke M.; Obeidat, Ma’en; Li, Xuan; Ng, Michael; Braybrooke, Rebecca; Molina-Molina, Maria; Hobbs, Brian D.; Putman, Rachel K.; Sakornsakolpat, Phuwanat; Booth, Helen L.; Fahy, William A.; Hart, Simon P.; Hill, Mike R.; Hirani, Nik; Hubbard, Richard B.; McAnulty, Robin J.; Millar, Ann B.; Navaratnam, Vidyia; Oballa, Eunice; Parfrey, Helen; Saini, Gauri; Whyte, Moira K. B.; Zhang, Yingze; Kaminski, Naftali; Adegunsoye, Ayodeji; Strek, Mary E.; Neighbors, Margaret; Sheng, Xuting R.; Gudmundsson, Gunnar; Gudnason, Vilmundur; Hatabu, Hiroto; Lederer, David J.; Manichaikul, Ani; Newell, John D., Jr.; O’Connor, George T.; Ortega, Victor E.; Xu, Hanfei; Fingerlin, Tasha E.; Bosse, Yohan; Hao, Ke; Joubert, Philippe; Nickle, David C.; Sin, Don D.; Timens, Wim; Furniss, Dominic; Morris, Andrew P.; Zondervan, Krina T.; Hall, Ian P.; Sayers, Ian; Tobin, Martin D.; Maher, Toby M.; Cho, Michael H.; Hunninghake, Gary M.; Schwartz, David A.; Yaspan, Brian L.; Molyneaux, Philip L.; Flores, Carlos; Noth, Imre; Jenkins, R. Gisli; Wain, Louise, V. Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 10.1164/rccm.201905-1017OC
  • Drake, Thomas M.; Docherty, Annemarie B.; Harrison, Ewen M.; Quint, Jennifer K.; Adamali, Huzaifa; Agnew, Sarah; Babu, Suresh; Barber, Christopher M.; Barratt, Shaney; Bendstrup, Elisabeth; Bianchi, Stephen; Villegas, Diego Castillo; Chaudhuri, Nazia; Chua, Felix; Coker, Robina; Chang, William; Crawshaw, Anjali; Crowley, Louise E.; Dosanjh, Davinder; Fiddler, Christine A.; Forrest, Ian A.; George, Peter M.; Gibbons, Michael A.; Groom, Katherine; Haney, Sarah; Hart, Simon P.; Heiden, Emily; Henry, Michael; Ho, Ling-Pei; Hoyles, Rachel K.; Hutchinson, John; Hurley, Killian; Jones, Mark; Jones, Steve; Kokosi, Maria; Kreuter, Michael; MacKay, Laura S.; Mahendran, Siva; Margaritopoulos, George; Molina-Molina, Maria; Molyneaux, Philip L.; O’Brien, Aiden; O’Reilly, Katherine; Packham, Alice; Parfrey, Helen; Poletti, Venerino; Porter, Joanna C.; Renzoni, Elisabetta; Rivera-Ortega, Pilar; Russell, Anne-Marie; Saini, Gauri; Spencer, Lisa G.; Stella, Giulia M.; Stone, Helen; Sturney, Sharon; Thickett, David; Thillai, Muhunthan; Wallis, Tim; Ward, Katie; Wells, Athol U.; West, Alex; Wickremasinghe, Melissa; Woodhead, Felix; Hearson, Glenn; Howard, Lucy; Baillie, J. Kenneth; Openshaw, Peter J. M.; Semple, Malcolm G.; Stewart, Iain; Jenkins, R. Gisli. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease An International Multicenter Study. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 10.1164/rccm.202007-2794OC
  • Kreuter, Michael; Polke, Markus; Walsh, Simon L. F.; Krisam, Johannes; Collard, Harold R.; Chaudhuri, Nazia; Avdeev, Sergey; Behr, Juergen; Calligaro, Gregory; Corte, Tamera; Flaherty, Kevin; Funke-Chambour, Manuela; Kolb, Martin; Kondoh, Yasuhiro; Maher, Toby M.; Molina, Maria; Morais, Antonio; Moor, Catharina C.; Morisset, Julie; Pereira, Carlos; Quadrelli, Silvia; Selman, Moises; Tzouvelekis, Argyrios; Valenzuela, Claudia; Vancheri, Carlo; Vicens-Zygmunt, Vanesa; Waelscher, Julia; Wuyts, Wim; Wijsenbeek, Marlies; Cottin, Vincent; Bendstrup, Elisabeth. Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation. EUROPEAN RESPIRATORY JOURNAL. 10.1183/13993003.01760-2019
  • Machahua C, Buendia-Roldan I, Ocaña-Guzman R, Molina-Molina M, Pardo A, Chavez-Galan L, Selman M . CD4+T cells in ageing-associated interstitial lung abnormalities show evidence of pro-inflammatory phenotypic and functional profile. THORAX. 10.1136/thoraxjnl-2020-215520

Research highlights

PROJECTS

3 Ongoing projects
1 Granted project

 

35 Ongoing clinical trials
13 Started clinical trials

PUBLISHED WORKS

5 Clinical Guidelines

Selected projects

  • Efecto de loratadina en linfangioleiomiomatosis (2020 – 2023) PI: MOLINA MOLINA, MARIA. Funder: FIS-Instituto de Salud Carlos III.
  • Caracterización de la fibrosis pulmonar telomérica y su regulación biológica (2019 – 2021) PI: MOLINA MOLINA, MARIA. Funder: FIS-Instituto de Salud Carlos III.
  • Ensayo de fase III, multicéntrico, aleatorizado, doble ciego, de administración crónica, con grupos paralelos y controlado con placebo para evaluar la eficacia y la seguridad de benralizumab 100 mg en pacientes con enfermedad pulmonar obstructiva crónica (EPOC) de moderada a muy grave y con antecedentes de exacerbaciones frecuentes de la epoc y eosinófilos elevados en sangre periférica (2020 – 2021) PI: SANTOS PEREZ, MARIA SALUD. Funder ref.: D3251C00014 (RESOLUTE).
  • Contrato de apoyo de ensayo clínico randomizado fase-II para evaluar el efecto de pirfenidona comparado con placebo en fibrosis pulmonar post-COVID19 (2020 – 2022) PI: MOLINA MOLINA, MARIA. Funder ref.: FIBRO-COVI (ML42510).
  • A phase II, randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and efficacy of mstt1041a or UTTR1147A in patients with severe COVID-19 pneumonia (2020 – 2021) PI: MOLINA MOLINA, MARIA. Funder ref.: GA42469.